ArticlemSphere2019
Open access · goldAbstract read
In one paragraph
Article in mSphere, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 34 citations in OpenAlex.
- Bacteriophage Sf14 survival under simulated gastrointestinal conditions.bioRxiv : the preprint server for biology · 2026Article
- Diverse Horizontally Transferred Cellulose Biosynthesis Gene Clusters inMicroorganisms · 2026Article
- Article
- Enhanced virulence and stress tolerance are signatures of epidemiologically successful Shigella sonnei.Nature communications · 2025Article
- A computational investigation into the role of tRNAs encoded by Shigella phage Sf14.BMC genomics · 2025Article
- Determinants of divergentmBio · 2025Article
- Development and Characterization of a Polyvalent Polyclonal Antibody as a Common Capture Antibody for the Detection of Enterotoxigenic Escherichia coli in a Sandwich ELISA.Current microbiology · 2025Article
- Surface Display of Type 1 Fimbriae onVaccines · 2025Article
- Characterization ofmBio · 2025Article
- Development of a Novel mRNA Vaccine AgainstBioinformatics and biology insights · 2025Article
- Loss to gain: pseudogenes in microorganisms, focusing on eubacteria, and their biological significance.Applied microbiology and biotechnology · 2024Review
- Epithelial Cell Infection Analyses with Shigella.Journal of visualized experiments : JoVE · 2024Article
- Shigella-Controlled Human Infection Models: Current and Future Perspectives.Current topics in microbiology and immunology · 2024Review
- A foundational approach to culture and analyze malnourished organoids.Gut microbes · 2023Article
- Pathogenicity and virulence ofVirulence · 2023Review
- Genome degradation promotesNational science review · 2023Article
- Evolution of cyclic di-GMP signalling on a short and long term time scale.Microbiology (Reading, England) · 2023Article
- Functional assays to evaluate antibody-mediated responses againstFrontiers in cellular and infection microbiology · 2023Review
- Genomic and proteomic characterization of two strains of Shigella flexneri 2 isolated from infants' stool samples in Argentina.BMC genomics · 2022Article
- The VirF21:VirF30 protein ratio is affected by temperature and impacts Shigella flexneri host cell invasion.FEMS microbiology letters · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 4 institutions in 1 country.
Rachael B Chanin *Mucosal Immunology and Biology Research Center, Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-4625-356X
Kourtney P Nickerson *Mucosal Immunology and Biology Research Center, Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital, Boston, Massachusetts, USA.
Alejandro Llanos-CheaMucosal Immunology and Biology Research Center, Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital, Boston, Massachusetts, USA.
Jeticia R SistrunkInstitute for Genome Sciences, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
David A RaskoInstitute for Genome Sciences, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-7337-7154
Deepak Kumar Vijaya KumarGenetics and Aging Research Unit, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
John de la ParraBiopharmaceutical Analysis Training Laboratory, Northeastern University Innovation Campus, Burlington, Massachusetts, USA.
Jared R AuclairBiopharmaceutical Analysis Training Laboratory, Northeastern University Innovation Campus, Burlington, Massachusetts, USA.
Jessica DingMucosal Immunology and Biology Research Center, Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital, Boston, Massachusetts, USA.
Kelvin LiMucosal Immunology and Biology Research Center, Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-3388-6421
Snaha Krishna DogiparthiMucosal Immunology and Biology Research Center, Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital, Boston, Massachusetts, USA.
Benjamin J D KusberMucosal Immunology and Biology Research Center, Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital, Boston, Massachusetts, USA.
Christina S FahertyMucosal Immunology and Biology Research Center, Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital, Boston, Massachusetts, USA csfaherty@mgh.harvard.edu.ORCID 0000-0002-3200-161X
Massachusetts General Hospital · USHarvard University · USNortheastern University · USUniversity of Maryland, Baltimore · US
Funding
Technology CoreU19AI110820 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI WHITE, OWEN R · 2014 to 2023
$36.5MWild-type S. typhi Infection in Humans: Integrated Immunoprotective MechanismsU19AI082655 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SZTEIN, MARCELO B. · 2009 to 2018
$27.8MInterdepartmental Neuroscience CenterP30NS045776 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BREAKEFIELD, XANDRA OWENS, TANNOUS, BAKHOS A · 2003 to 2018
$11.1MSignaling Pathways in Innate ImmunityT32AI095190 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Stefanie N. Vogel · 2012 to 2026
$4.7MMGHfC Digestive Disease Summer Research ProgramR25DK103579 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BRYAN P HURLEY · 2015 to 2026
$1.2MThe mechanism of Shigella flexneri adherence during the early infection processK22AI104755 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI FAHERTY, CHRISTINA S · 2014 to 2015
$270kRequest for electron microscopeS10RR023594 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI DIFIGLIA, MARIAN · 2010 to 2010
$194kNCRR NIH HHS S10 RR023594NIAID NIH HHS K22 AI104755NIAID NIH HHS T32 AI095190NIAID NIH HHS U19 AI082655NIAID NIH HHS U19 AI110820NIDDK NIH HHS R25 DK103579NINDS NIH HHS P30 NS045776
Abstract
The
Indexed as
Bacterial AdhesionGene Expression Regulation, BacterialAdhesins, BacterialBile Acids and SaltsBiofilmsCells, CulturedEpithelial CellsGene Expression ProfilingGlucoseHost-Pathogen InteractionsHumansOperonShigella flexneriAdhesins, BacterialBile Acids and SaltsGlucoseadherence factorsbile saltsbiofilmcurliepithelial cellsglucoseintestinalin vivo-like conditionslong polar fimbriaeShigella flexneritype 1 fimbriae
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.